Tumor immune microenvironment in pituitary neuroendocrine tumors (PitNETs): increased M2 macrophage infiltration and PD-L1 expression in PIT1-lineage subset

被引：0
|
作者：
Mei Luo
Rui Tang
Haijun Wang
机构：
[1] Sun Yat-Sen University,Department of Neurosurgery and Pituitary Tumor Center, The First Affiliated Hospital
[2] Central South University,Department of Rheumatology and Immunology, The Second Xiangya Hospital
来源：
Journal of Neuro-Oncology | 2023年 / 163卷
关键词：
PitNETs; PIT1; M2-macrophage; PD-L1; Immunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：663 / 674
页数：11
相关论文
共 50 条
  • [1] Tumor immune microenvironment in pituitary neuroendocrine tumors (PitNETs): increased M2 macrophage infiltration and PD-L1 expression in PIT1-lineage subset
    Luo, Mei
    Tang, Rui
    Wang, Haijun
    JOURNAL OF NEURO-ONCOLOGY, 2023, 163 (03) : 663 - 674
  • [2] PD-L1 Expression in Pituitary Neuroendocrine Tumors/Pituitary Adenomas
    Cossu, Giulia
    La Rosa, Stefano
    Brouland, Jean Philippe
    Pitteloud, Nelly
    Harel, Ethan
    Santoni, Federico
    Brunner, Maxime
    Daniel, Roy Thomas
    Messerer, Mahmoud
    CANCERS, 2023, 15 (18)
  • [3] Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
    Koirala, Pratistha
    Roth, Michael E.
    Gill, Jonathan
    Piperdi, Sajida
    Chinai, Jordan M.
    Geller, David S.
    Hoang, Bang H.
    Park, Amy
    Fremed, Michael A.
    Zang, Xingxing
    Gorlick, Richard
    SCIENTIFIC REPORTS, 2016, 6
  • [4] Pyruvate Kinase M2 Is Required for the Expression of the Immune Checkpoint PD-L1 in Immune Cells and Tumors
    Palsson-McDermott, Eva M.
    Dyck, Lydia
    Zaslona, Zbigniew
    Menon, Deepthi
    McGettrick, Anne F.
    Mills, Kingston H. G.
    O'Neill, Luke A.
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [5] Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors
    Mei, Yu
    Bi, Wenya Linda
    Greenwald, Noah F.
    Du, Ziming
    Agar, Nathalie Y. R.
    Kaiser, Ursula B.
    Woodmansee, Whitney W.
    Reardon, David A.
    Freeman, Gordon J.
    Fecci, Peter E.
    Laws, Edward R., Jr.
    Santagata, Sandro
    Dunn, Gavin P.
    Dunn, Ian F.
    ONCOTARGET, 2016, 7 (47) : 76565 - 76576
  • [6] Expression of programmed death-ligand 1 (PD-L1) in human pituitary neuroendocrine tumor
    Suteau, Valentine
    Collin, Alexandre
    Menei, Philippe
    Rodien, Patrice
    Rousselet, Marie-Christine
    Briet, Claire
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (10) : 2053 - 2061
  • [7] Expression of programmed death-ligand 1 (PD-L1) in human pituitary neuroendocrine tumor
    Valentine Suteau
    Alexandre Collin
    Philippe Menei
    Patrice Rodien
    Marie-Christine Rousselet
    Claire Briet
    Cancer Immunology, Immunotherapy, 2020, 69 : 2053 - 2061
  • [8] Tumor Infiltrating Lymphocytes and PD-L1 Expression Differ in Low and High Grade Neuroendocrine Tumors
    Grabowski, P.
    Joehrens, K.
    Arsenic, R.
    Kaemmerer, D.
    Hummel, M.
    Scheibenbogen, C.
    Busse, A.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 107 - 108
  • [9] Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients
    Weyerer, Veronika
    Strissel, Pamela L.
    Strick, Reiner
    Sikic, Danijel
    Geppert, Carol I.
    Bertz, Simone
    Lange, Fabienne
    Taubert, Helge
    Wach, Sven
    Breyer, Johannes
    Bolenz, Christian
    Erben, Philipp
    Schmitz-Draeger, Bernd J.
    Wullich, Bernd
    Hartmann, Arndt
    Eckstein, Markus
    CANCERS, 2021, 13 (10)
  • [10] Association of Expression of PD-L1 with the Tumor Immune Microenvironment in Small Cell Lung Cancer
    Yu, Hui
    Badzio, Andrzej
    Boyle, Theresa A.
    Chan, Dan
    Rivard, Christopher J.
    Lu, Xian
    Kowalewski, Ashley A.
    Ellison, Kim
    Hirsch, Fred R.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S222 - S223
12345